Brown, Samuel
Nassar, Kholoud
Razzouk, Jacob
Kashyap, Abishek K.
Won, Mitchell
Shehadeh, Thaer
Salabat, Reza
Rabkin, David G.
Chung, Joshua S.
Article History
Received: 8 May 2023
Accepted: 21 November 2023
First Online: 29 November 2023
Declarations
:
: Our study design was submitted to the Loma Linda University Medical Center Institutional Review Board. The Institutional Review Board determined that there was minimal risk to research subjects. Given the retrospective nature of the study Informed Consent was waived per 45 CFR 46.116(d) and HIPAA authorization was waived per 45 CFR 164.512 (1)(2)(ii) therefore we received approval for our study (IRB# 5220263) on August 16, 2022.
: The authors declare that they have no competing interests.